Effect of crossover from placebo to darolutamide on overall survival in men with non-metastatic prostate cancer: sensitivity analyses from the randomised phase 3 ARAMIS study von Shore, Neal D., Fizazi, Karim, Tammela, Teuvo L.J., Luz, Murilo, Salas, Manuel Philco, Ouellette, Paul, Lago, Sérgio, Bastos, Diogo Assed, Kenneth Jansz, G., Cárcano, Flavio Mavignier, Andrade, Lívia, Pliskin, Marc, Lazaretti, Nicolas, Arruda, Larissa, Ochoa, José Jaime Correa, Kuss, Iris, Kappeler, Christian, Sarapohja, Toni, Smith, Matthew

Volltext

954 Clinical results from a phase I dose escalation study in treatment-naïve early stage prostate cancer patients with ORCA-010, a potency enhanced oncolytic replication competent... von Brachtlova, Tereza, Abramovitch, Allan, Giddens, Jonathan, Incze, Peter, Jansz, Kenneth, Casey, Richard, Beusechem, Victor van, Dong, Wenliang

Volltext

Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer von Fizazi, Karim, Shore, Neal, Tammela, Teuvo L, Ulys, Albertas, Vjaters, Egils, Polyakov, Sergey, Jievaltas, Mindaugas, Luz, Murilo, Alekseev, Boris, Kuss, Iris, Kappeler, Christian, Snapir, Amir, Sarapohja, Toni, Smith, Matthew R

Volltext

Liproca Depot: A New Antiandrogen Treatment for Active Surveillance Patients von Klotz, Laurence, Grudén, Stefan, Axén, Niklas, Gauffin, Charlotta, Wassberg, Cecilia, Bjartell, Anders, Giddens, Jonathan, Incze, Peter, Jansz, Kenneth, Jievaltas, Mindaugas, Rendon, Ricardo, Richard, Patrick O., Ulys, Albertas, Tammela, Teuvo L.

Volltext

Genetic testing practices among specialist physicians who treat prostate cancer: A Canadian cross-sectional survey von Yip, Steven M, Morash, Christopher, Kolinsky, Michael P, Kapoor, Anil, Ong, Michael, Selvarajah, Shamini, Nuk, Jennifer, Compton, Katie, Pouliot, Frederic, Lavallée, Luke T, Khalaf, Daniel J, Hamilton, Robert J, Gotto, Geoffrey T, Rendon, Ricardo A, Antebi, Elie, Hotte, Sebastien J, Malone, Shawn, Chi, Kim N, Drachenberg, Darrel E, Saad, Fred, Chan, Jonathan, Ferrario, Cristiano, Ko, Jenny, Shayegan, Bobby, Parimi, Sunil, So, Alan I, Feifer, Andrew, Jansz, Kenneth, Finch, Daygen, Chin, Joseph L, Osborne, Brendan, Ho, Kai Fai, Galamo, Corine Demanga, Zardan, Anousheh, Niazi, Tamim

Volltext

Analysis of the effect of crossover from placebo (PBO) to darolutamide (DARO) on overall survival (OS) benefit in the ARAMIS Trial von Shore, Neal D., Fizazi, Karim, Tammela, Teuvo, Luz, Murilo, Philco Salas, Manuel, Ouellette, Paul, Lago, Sergio, Bastos, Diogo Assed, Jansz, G. Kenneth, Carcano, Flavio Mavignier, Andrade, Livia, Pliskin, Marc, Lazaretti, Nicolas, De Arruda, Larissa, Correa, Jose Jaime, Petrenciuc, Oana, Kappeler, Christian, Sarapohja, Toni, Smith, Matthew Raymond

Volltext

Recanalization of an atretic left internal mammary graft after bypass surgery for an anomalous left main coronary artery origin: a case report von Meredith, Thomas, Jansz, Paul, Sesel, Kenneth, Kathir, Krishna

Volltext

Recanalization of an atretic left internal mammary graft after bypass surgery for an anomalous left main coronary artery origin: a case report von Meredith, Thomas, Jansz, Paul, Sesel, Kenneth, Kathir, Krishna

Volltext